School of Medicine

Research from the lab of Hong Chen, at the McKelvey School of Engineering and the School of Medicine, and collaborators found that using focused-ultrasound-mediated liquid biopsy in a mouse model released more tau proteins and another biomarker into the blood than without the intervention. This noninvasive method could facilitate diagnosis of neurodegenerative disorders.

A new study led by the School of Medicine reveals at least one cause of low white blood cell counts in patients treated for glioblastoma and demonstrates a potential treatment strategy that improves survival in mice.

Jeffrey I. Gordon, MD, at the School of Medicine, has been named this year’s recipient of the Dr. Paul Janssen Award for Biomedical Research.

Researchers at the School of Medicine have identified a previously unknown signaling pathway cells use to protect their DNA while it is being copied. The findings suggest a way that could boost the potency of cancer therapeutics.

Shu Jiang, an associate professor of surgery at the School of Medicine, has earned a spot on Forbes’ “30 Under 30” in health care list.

Timothy J. Eberlein, MD, the Spencer T. and Ann W. Olin Distinguished Professor and director of Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine, has been elected chair of the American College of Surgeons Board of Regents.

A new study by researchers at Washington University School of Medicine found that the quality of care for lung cancer in the U.S. varies widely. The findings show that high-quality care is associated with improved overall survival rates among patients with lung cancer.

Gut bacteria can influence brain health, according to a study of mice genetically predisposed to develop Alzheimer’s-like brain damage. The School of Medicine study findings suggest a new approach to treating Alzheimer’s and other neurodegenerative diseases.

A School of Medicine study may help explain how excess weight can contribute to diabetes and may provide researchers with a target to help prevent or delay diabetes in some of those at risk. The findings suggest that many people with elevated levels of insulin also have defects in an enzyme important to the processing of a key fatty acid.

A study, in mice, from the School of Medicine, suggests that the bacterium Acinetobacter can hide undetected in bladder cells and then reactivate when stimulated by medical intervention. The findings suggest that patients may bring the bacterium into hospitals.